DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty retailer of hydroponic and organic gardening products, today announced it will showcase its latest innovations at Cultivate’25, Booth #1353, to be held July 12–15, 2025, at the Greater Columbus Convention Center in Columbus, Ohio. Cultivate’25 is the premier horticulture trade show for greenhouse growers, nurseries, and lawn & garden professionals. Attendees can explore ...

PRELIMINARY NET ASSET VALUE PER SHARE AS OF JUNE 30, 2025, OF $4.80THE FILING OF AN UPDATED PRELIMINARY JOINT PROXY STATEMENT/PROSPECTUS FOR PROPOSED BUSINESS COMBINATION WITH MOUNT LOGAN CAPITAL INC. PLAN TO SCHEDULE SHAREHOLDER CALL DURING WEEK OF JULY 14, 2025. MONTCLAIR, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) today announced its preliminary net asset value (“NAV”) per share as of June 30, 2025, of $4.80, which is an increase of approximately ...

Two additional EDCs accelerates rollout, expanding edge infrastructure and increasing carrier accessJACKSONVILLE, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions tailored to meet evolving needs in any environment, today announced the upcoming deployment of two new EDCs in Corpus Christi, Texa ...

JUPITER, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Pelthos Therapeutics Inc. (NYSE American: PTHS) has commercially launched ZELSUVMI™ (berdazimer) topical gel 10.3%, the first and only FDA-approved at-home treatment for molluscum contagiosum. The Company has earned a $5 million milestone payment from Pelthos following the commercial launch of ZELSUVMI. “Molluscum impacts millions of people in the U.S., particularly children. ...

Q2 Revenue Grows 41% Year-Over-Year to a Record $28.5 Million as Byrna Introduces New Compact Launcher and Increases Dealer Sales 106% Over Prior Year on the Back of the Sportsman’s Warehouse PartnershipANDOVER, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for ...

Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with confidence, care, and convenienceHealth checks include assessments for heart health, memory, cognitive function, and mental healthNo travel required — all appointments are virtual and confidentialCommunity Health Workers provide personalized follow-up support and connect patients to local resourcesThe program is now available in New York City, with plans to expand ...

MANCHESTER, N.H., July 10, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it plans to release financial results for its first quarter fiscal year 2026 prior to the market open on Thursday, July 31, 2025. Following the press release, Mike Doogue, President and Chief Executive Officer, and Derek D’Antilio, Executive Vice President and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time to discuss the Company’s results and business outlook. Analyst ...

NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), will present new findings at the upcoming Alzheimer's Association International Conference (AAIC®) 2025 in Toronto. The presentations include a cost savings analysis of the use of pTau217 as a screening tool in Acumen’s Phase 2 ALTITUDE-AD trial ...

文章核心观点 BullFrog AI推出新的BullFrog Data Networks™ Solutions Library，借助领先云平台支持，为大型药企提供企业级药物开发解决方案，有望加速药物研发周期并带来可预测收入 [1][3][7] 分组1：新解决方案介绍 - 新的BullFrog Data Networks™ Solutions Library是企业级进化版数据洞察平台，由bfLEAP™因果AI引擎驱动 [1] - 预计2025年晚些时候推出，专为大型药企等组织设计，可从海量生物医学数据集提取见解 [2] - 平台按专业领域分为解决方案模块，可获取针对性见解或构建定制决策支持系统 [2] 分组2：云平台支持优势 - 该解决方案库获谷歌云、微软Azure和亚马逊AWS原生部署支持，具备高可扩展性、正常运行时间和信息安全性 [3] - 与云平台合作确保公司处理敏感生物医学数据时符合全球数据隐私和安全标准 [3] - 无论在云端还是混合环境，公司能满足企业数据存储需求，实现无缝数据访问和快速入职 [4] - 借助云原生弹性和全球覆盖，可快速部署bfLEAP™平台，让客户快速深入探索生物标志物等 [5] 分组3：企业级药物开发优势 - 新解决方案库基于原BullFrog Data Networks™成功经验，加强公司在AI驱动药物研发领域的领先地位 [6] - 为大型药企降低研发成本和失败率，提供贯穿开发生命周期的差异化见解 [6] - 设计用于可扩展部署，通过与顶级药企长期合作提供模块化分析组件，实现可预测订阅式收入 [7] 分组4：行业市场情况 - 据Polaris Market Research，到2034年全球AI药物发现市场预计达354亿美元，复合年增长率29.6% [8] 分组5：公司概况 - BullFrog AI利用人工智能和机器学习推进药物研发，通过与研究机构合作分析生物数据，减少临床试验失败率 [10]

Partnership combines best-in-class review management with AI-powered local marketing solutions for professionals and tradesSAN FRANCISCO, CA AND PERTH, AUSTRALIA, July 10, 2025 (GLOBE NEWSWIRE) -- Experience.com, a global leader in customer experience, reputation management, and online visibility, today announced the appointment of Locafy Limited (Nasdaq: LCFY), a recognized innovator in location-based digital marketing, as its newest partner in the Asia-Pacific (APAC) region. Under the partnership agreemen ...